Volume : 09, Issue : 06, June – 2022

Title:

51.REVIEW OF MATRIX TYPE TRANSDERMAL PATCHES OF BENAZEPRIL HYDROCHLORIDE
‬

Authors :

Mr. Tanvir. Y. Shaikh, Miss. Himali .R. Patil*, Dr. Bharat .V. Jain,Dr. Sandip. R. Pawar

Abstract :

Transdermal drug delivery systems are defined as self-contained, discrete dosage forms which, when applied to the intact skin, deliver the drug(s), through the skin, at a controlled rate to the circulation (Monkhouse and Huq, 1988).
FDA approved the primary skin patch products in 1981. These delivery systems provided the controlled systemic absorption of scopolamine for the prevention of sickness (TransdermScop, ALZA Corp.) and nitroglycerine for the prevention of angina related to arterial blood vessel disease (Transderm‐Nitro). Over the last twenty years, over 35 transdermal products are approved generating sales of $3.2 billion in 2002, which is predicted to rise to $4.5 billion in 2008. More recently, such dosage forms are developed and/or modified so as to reinforce the actuation of drug diffusion (thermodynamic activity) and/or increase the permeability of the skin. These approaches include the employment of penetration enhancers, supersaturated systems, prodrugs, liposomes and other vesicles (Bhavna yadav et al., 2011).
KEYWORDS- Transdermal Patches, Benazepril Hydrochloride, Eudragit L100.

Cite This Article:

Please cite this article in press Miss. Himali .R. Patil et al, Review Of Matrix Type Transdermal Patches Of Benazepril Hydrochloride., Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10

References:

1. Agrawal S., Girish K. Jain., A.K. Sharma., 1996. Transdermal controlled administration of verapamil enhancement of skin permeability. Int. J. Pharm. 130. 169 – 177.
2. Aisha Khanum., Vinay Pandit., Shyamala Bhaskaran., Vasiha Banu., 2008. Preparation and evaluation of Tolterodine tartarate transdermal films for the treatment of overactive bladder. RJPT. 1(4). 516-521.
3. Alfons Schnitzler., Karl – Werner Leffers., Hermann – Josef Hack., 2010. High compliance with rotigotine transdermal patch in the treatment of idiopathic Parkinson’s disease. Parkinsonism and Related Disorders. 16. 513 – 516.
4. Alireza Ghaffari., Kian Navaee., Mahvash Oskoui., Khosrow bayati., Morteza Rafiee-Tehrani., 2007. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit® RS intended for sigmoidal drug delivery. Eur. J. Pharm. Biopharm. 67.175-186.
5. Anilreddy B., 2010. Invitro characterization and evaluation of transdermal drug delivery system for Metoprolol Tartarate. JPRHC. 2(4). 325-329.
6. Anthony C Moffat., 2004. Clarke’s Analysis of Drugs and Poisons in pharmaceuticals. Body fluids and postmortem materials. Pharmaceutical Press, London. 3rd edi. 675 – 676.
7. Arijit Das., Sibaji Ghosh., Biplab Kr. Dey., Sudip Das., 2010. A novel technique for treating the type-II diabetes by transdermal patches prepared by using multiple polymer complexes. IJPRD. 2(9). 195-204.
8. Ashok kumar J, Nikhila pullakandam, Lakshmana prabu S, Gopal V., 2010. Transdermal drug delivery system: an overview. Int. J. Pharm. Sci. Rev. Res. 3(2). 49 – 54.
9. Ashu Mittal., Udai Vir Sing Sara., Asgar Ali., 2009. Formulation and evaluation of monolithic matrix polymer films for transdermal delivery of nitrendipine. Acta Pharm. 59. 383-393.
10. Barbara Rolando., Loretta Lazzarato., Antonella Di Stilo., Roberta Fruttero., 2010. Physicochemical profile and invitro permeation behavior of a new class of non – steroidal anti – inflammatory drug candidates. Eur. J. Pharm. Sci. 40. 217 – 221.
11. Beata Stanisz., Sylwia Paszun., Marcin Lesniak., 2009. Validation of UV derivative spectrophotometric method for determination of Benazepril Hydrochloride in Tablet and evaluation of its stability. Acta Poloniae Pharm. Drug. Res. 66. 343-349.
12. Belal F., I.A. Al – Zaagi., Abounassif M.A., 2000. Spectrophotometric determination of benazepril in tablets. Farmaco. 55. 425 – 432.
13. Bhaskatiya M., R.K. Nema., Bhatnagar M., 2010. Designing and Characterization of Drug Free Patches for Transdermal Application. Int. J. Pharm. Sci. Drug Res. 2(1). 35 –39.
14. Bhavna yadav., Kamal saroha., Benika sharma., 2011. Transdermal patch: a discrete dosage form. Int. J. Current. Pharm. Res. 3 (3). 98 – 108.
15. Biswajit Mukherjee., Sushmita Mahapatra., Ritu Gupta., Balaram patra., Amit Tiwari., Priyanka Arora., 2005. A comparision between povidone-ethylcellulose and povidone-eudragit transdermal Dexamethasone matrix patches based on invitro skin permeation. Eur. J. Pharm. Biopharm. 59. 475-483.
16. Charles M. Heard., Christopher W. Jeans., 1999. A therapeutic dose of primaquine can be delivered across excised human skin from simple transdermal patches. Int. J. Pharm. 189. 1 – 6.
17. Charles M. Heard., Rachel J. Batchelder., Richard J. Calder., Chris P. Thomas., 2004. Invitro transdermal delviery of the major catechins and caffeine from extract of Camellia sinensis. Int. J. Pharm. 283. 45 – 51.
18. Chien Y.W., 2005. Novel Drug Delivery Systems. Marcel Dekker, New York. 2nd edition. volume 1. 1 – 2.
19. Chung SJ., 1999. Future drug delivery research in south korea. J. Control. Rel. 62. 73-9. Colin Dollery., 1999. Therapeutic Drugs. Churchil livingstone., Edinburgh. 2nd Edit. B12 to B16.
20. Dipen M. Patel, Kavitha K., 2011. Formulation and evaluation aspects of transdermal drug delivery system. Int. J. Pharm. Sci. Rev. Res. 6 (2). 83 – 90.
21. Divyesh Patel., Nirav Patel., Meghal Parmar., Navpreet Kaur., 2011. Transdermal drug delivery system:review. Int. J. Biopharm. Toxi. Res. 1(1). 61-80.
22. Douw G. Muller., Johannes P. Venter., Jeanetta du Plessis., Colleen Goosen., 2001. A comparative study of an in situ adapted diffusion cell and an in vitro Franz diffusion cell method for transdermal absorption of doxylamine. Eur. J. Pharm. Sci. 13. 169-177.European Pharmacopoeia 5.0.

23. Eva Gutschke., Stefan Bracht., Stefan Nagel., Werner Weitschies., 2010. Adhesion testing of transdermal matrix patches with a probe tack test – In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 75. 399 – 404.
24. Foco A., Hadziabdic J., Becic F., 2004. Transdermal drug delivery systems. Med. Arch. 58. 230-4.